These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4633975)

  • 1. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B
    Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimeningococcal vaccination in member States of the Organization for Coordination and Cooperation in the Control of Major Epidemics].
    Etienne J
    Prog Immunobiol Stand; 1971; 5():492-6. PubMed ID: 4633976
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 4. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meningococcal infections: vaccination and prevention by drugs].
    Herzog C
    Ther Umsch; 1983 Mar; 40(3):239-43. PubMed ID: 6407135
    [No Abstract]   [Full Text] [Related]  

  • 6. Further conquest of the meningococcus.
    Lepow ML; Gold R
    N Engl J Med; 1977 Sep; 297(13):721-2. PubMed ID: 408684
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunological characteristics in children given meningococcal group A polysaccharide vaccine developed at the G. N. Gabrichevskĭ Moscow Research Institute of Epidemiology and Microbiology].
    Skirda TA; Golovina LI; Mishina AI; Chernyshova TF; Savchenko LG; Chernyshova MS
    Pediatriia; 1992; (2):55-9. PubMed ID: 1513635
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serologic evaluation of the efficiency of meningococcal capsular polysaccharide vaccines of serogroups A and C: correlation with age, dosage, previous immune status and serological assays].
    Veronesi R; Fayet MT; Stellmann C; Takeda AK; Feldman C; Focaccia R; Mazza CC; Oliveira CE; Sebe E; Adelino M; Diniz JM; Zuccas WA
    Rev Hosp Clin Fac Med Sao Paulo; 1977; 32(5):296-305. PubMed ID: 392678
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tests of anti-meningococcal vaccination with A and C group polysaccharide vaccines].
    Galli MG; Fara GM; Saletti M; Porro M; Ribero ML
    Ann Sclavo; 1981; 23(3):356-66. PubMed ID: 6803687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of polysaccharide vaccines for the prevention of meningococcal diseases.
    Gotschlich EC
    Monogr Allergy; 1975; 9():245-58. PubMed ID: 804088
    [No Abstract]   [Full Text] [Related]  

  • 14. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine research: new vaccines and evidence of vaccine safety.
    Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: prophylaxis for contacts of patients with meningococcal disease.
    Gold R
    Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal polysaccharide vaccines: recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1977 Sep; 16(9):764-5. PubMed ID: 408072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Why and when to vaccinate against meningococcal disease].
    Humble M
    Nord Med; 1984; 99(10):248-50, 253. PubMed ID: 6436785
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serological evaluation of an antimeningococcal mass vaccination campaign in Niger].
    Rey JL; Soubiran G; Fayet MT; Triau R
    Bull Soc Pathol Exot Filiales; 1989; 82(2):248-54. PubMed ID: 2501041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.